Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,018 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement].
Cybulska B, Gaciong Z, Hoffman P, Jankowski P, Kłosiewicz-Latoszek L, Kaźmierczak J, Mitręga K, Opolski G, Pająk A, Ponikowski P, Rynkiewicz A, Stępińska J, Średniawa B, Kalarus Z. Cybulska B, et al. Among authors: ponikowski p. Kardiol Pol. 2016;74(4):394-8. doi: 10.5603/KP.2016.0051. Kardiol Pol. 2016. PMID: 27098076 Free article. Polish.
[New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologists consensus statement].
Pruszczyk P, Stępińska J, Banasiak W, Członkowska A, Opolski G, Niewada M, Ponikowski P, Tendera M, Windyga J. Pruszczyk P, et al. Among authors: ponikowski p. Kardiol Pol. 2012;70(9):979-88. Kardiol Pol. 2012. PMID: 22993019 Polish. No abstract available.
Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy.
Dąbrowski R, Opolski G, Włodarczyk P, Kiliszek M, Ponikowski P. Dąbrowski R, et al. Among authors: ponikowski p. Kardiol Pol. 2014;72(8):700-6. doi: 10.5603/KP.a2014.0067. Epub 2014 Mar 27. Kardiol Pol. 2014. PMID: 24671916 Free article.
Hospitalisation length and prognosis in heart failure patients.
Zaprutko J, Michalak M, Nowicka A, Dankowski R, Drożdż J, Ponikowski P, Opolski G, Nessler J, Nowalany-Kozielska E, Szyszka A. Zaprutko J, et al. Among authors: ponikowski p. Kardiol Pol. 2017;75(4):323-331. doi: 10.5603/KP.a2016.0183. Epub 2016 Dec 20. Kardiol Pol. 2017. PMID: 27995602 Free article.
Sacubitril/valsartan for treatment of chronic heart failure with reduced ejection fraction. Can all patients benefit? A position statement paper of experts of the Heart Failure Working Group of the Polish Cardiac Society.
Straburzyńska-Migaj E, Nessler J, Gruchała M, Kamiński K, Lelonek M, Leszek P, Mizia-Stec K, Rozentryt P, Gackowski A, Gwizdała A, Jankowska EA, Ponikowski P. Straburzyńska-Migaj E, et al. Among authors: ponikowski p. Kardiol Pol. 2017;75(3):286-293. doi: 10.5603/KP.2017.0056. Kardiol Pol. 2017. PMID: 28326531 Free article. No abstract available.
[Coordinated heart failure care in Poland: towards optimal organisation of the health care system].
Nessler J, Kozierkiewicz A, Gackowski A, Ponikowski P, Straburzynska-Migaj E, Uchmanowicz I, Hoffman P, Chlebus K, Gielerak G, Gąsior M, Grodzicki T, Gierczyński J, Jankowski P, Kaźmierczak J, Legutko J, Leszek P, Miłkowski M, Opolski G, Rozentryt P, Windak A, Witkowski A, Wysocki MJ, Zapaśnik A, Zdrojewski T. Nessler J, et al. Among authors: ponikowski p. Kardiol Pol. 2018;76(2):479-487. doi: 10.5603/KP.2018.0050. Kardiol Pol. 2018. PMID: 29457624 Free article. Polish.
1,018 results